Clifford Chance has advised Tillotts Pharma AG on the deal. Tillotts Pharma AG agreed to acquire the rights to the drug DIFICLIRTM™ from Astellas Pharma Europe…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now